Whole Network Gene Therapy Microbiology Nanomedicine Stem Cells

 

FDA Approves Lucentis For Age-Related Vision Loss

Filed in archive Drugs, Vaccines and Therapeutics by ruth on July 3, 2006

FDA Approves Lucentis For Age-Related Vision Loss
After a 6-month priority review, the U.S. Food and Drug Administration (FDA) has approved Genentech's drug against age-related macular degenerationlinks (AMD). LUCENTIS™ (ranibizumab) is an antibody fragment which works by binding and inhibiting Vascular Endothelial Growth Factor, VEGF-A, a protein that is believed to play a critical role in angiogenesis (the formation of new blood vessels). It will be administered via monthly intravitreal injections.

Genetech officials say Lccentis is the first therapy to improve vision in wet AMD patients. Highlights of the pivotal clinical studies that led to this approval are discussed in the company press release. A reply of a webcast by the Genentech management on the approval may be accessed until July 7 at the company website. Access numbers for this replay are: 1-800-642-1687 (U.S./Canada) and 1-706-645-9291 (international); Conference ID number is 1794492.






Permalink: FDA Approves Lucentis For Age-Related Vision Loss
Tags: vision  blindness  biotech  related  approves  approves+lucentis  related+vision  vision+loss 

Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/26528





RSSrss   | See all blog subscribe options
Google google   |   What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter
Grouptivity

Use the search to look for other interesting posts



 
  • Advertise with us

  • Learn more about our advertising options or email advertising - at - creative-weblogging.com or give us a call at +1 (650) 331 4900.


  • Testimonials

  • 'Very nice blog layout with great content. Are you interested in Star Trek props that are quickly becoming reality? Then this is the blog for you. Human medical scanners, nano technology and more great technological advancements.' -VirtualLoop Blog of the Week

    'I subscribe to your blog and have been enjoying your posts and perspective.'


  • Other blogs in the same channel in the Creative Weblogging Network







 

Tagcloud: Biotech Hubs and Facilities Biotech/Science Blogs Corporate and Industrial News Diagnostics, Methodologies and Instrumentation Drugs, Vaccines and Therapeutics Energy, Environment and Ecology Food and Agriculture Gene Therapy Genomics, Proteomics and Bioinformatics Meetings and Other Events Microbiology Nanomedicine Other Biotechnology News Patents and Intellectual Property Rights Sponsored Post Stem Cells